Epigenetic regulation adds further complexity: downregulation or hypermethylation of TET2 has been associated with worse CRC prognosis [23], whereas genetically predicted AD has been linked to reduced CRC risk through TET2-mediated immune modulation [37]. Here, TET2 is linked to colorectal carcinoma.